Experience

Thomas Blinka

    • Obtained the first US patents covering combination HIV therapies for Gilead Sciences 


    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 


    • Global cross-license achieved for Gevo in long-running biofuels patent case 


    • Kyle Bass’ attacks on multiple Horizon Pharma patents is blocked 


    • Vitae Pharmaceuticals Completes Initial Public Offering  


    • Cara Therapeutics $55 Million Initial Public Offering 


    • AcelRx Pharmaceuticals in Public Offering 


    • Otsuka $825 Million Collaboration Agreement to Develop Alzheimer's Drug